European Commission approves Keytruda plus Trastuzumab and chemotherapy as first-line treatment for GEJ
KEYTRUDA is the first immunotherapy approved in the EU for the first-line treatment of this patient population
KEYTRUDA is the first immunotherapy approved in the EU for the first-line treatment of this patient population
Novo Nordisk’s GLP-1 Ozempic has reported a YoY increase in revenue from $2.1 billion to $3.2 billion
Hospital joins with Intuitive to install da Vinci systems to support enhanced healthcare delivery and patient outcomes across India
The refrigerators and freezers are the latest offering in Thermo Fisher’s industry-leading portfolio of smart lab solutions
Aims to build the largest connected healthcare ecosystem in India
The 100 surgeries conducted using robotic technology span various intricate procedures in the fields of Urology, Liver Transplantation, GI surgery, Cardiac surgeries and Gynaecology
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
First PARP inhibitor approved in Japan to demonstrate clinically meaningful benefits in combination with a new hormonal agent
Centre aims to train surgeons and other healthcare professionals from India and Southeast Asia in robotic-assisted surgery
Subscribe To Our Newsletter & Stay Updated